Cytosorbents Corporation (CTSO) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 17.76M | 20.63M | 21.31M | 22.99M | 25.41M | 21.6M | 16.6M | 21.96M | 19.99M | 25.7M | 19.26M | 23.64M |
| Cash & Short-Term Investments | 4.81M | 6.25M | 7.54M | 10.2M | 11.59M | 3.28M | 5.69M | 8.46M | 8.61M | 14.13M | 8.36M | 13.15M |
| Cash Only | 4.81M | 6.25M | 7.54M | 10.2M | 11.59M | 3.28M | 5.69M | 8.46M | 8.61M | 14.13M | 8.36M | 13.15M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 7.15M | 7.55M | 7.43M | 7.74M | 7.67M | 7.32M | 6.63M | 7.82M | 6.77M | 6.06M | 6.18M | 7.02M |
| Days Sales Outstanding | 74.64 | 74.61 | 73.57 | 72.92 | 77.29 | 70.14 | 77.2 | 75.07 | 64.9 | 76.59 | 78.33 | 60.62 |
| Inventory | 4.48M | 5.28M | 4M | 3.71M | 3.02M | 2.73M | 3.25M | 4.32M | 3.74M | 3.68M | 2.98M | 2.05M |
| Days Inventory Outstanding | 160.68 | 175.73 | 125.84 | 109.22 | 102.72 | -1.11K | 84.69 | 156.7 | 159.53 | 130.5 | 72.12 | 50.44 |
| Other Current Assets | 1.31M | 1.55M | 2.35M | 1.33M | 3.14M | 8.27M | 1.03M | 0 | 0 | 1.83M | 1.75M | 1.42M |
| Total Non-Current Assets | 22.8M | 23.55M | 24.44M | 25M | 25.37M | 25.77M | 31.21M | 31.47M | 27.08M | 27.56M | 28.31M | 28.8M |
| Property, Plant & Equipment | 18.28M | 18.75M | 19.27M | 19.69M | 20.09M | 20.51M | 20.92M | 21.21M | 21.67M | 22.12M | 22.48M | 22.84M |
| Fixed Asset Turnover | 0.48x | 0.49x | 0.49x | 0.48x | 0.43x | 0.44x | 0.41x | 0.41x | 0.41x | 0.33x | 0.34x | 0.41x |
| Goodwill | 0 | 3.23M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 3.74M | 3.7M | 3.75M | 0 | 0 | 0 | 3.91M | 0 | 0 |
| Long-Term Investments | 0 | 1.52M | 0 | 1.52M | 1.52M | 0 | 6.48M | 0 | 0 | 1.48M | 1.69M | 1.69M |
| Other Non-Current Assets | 4.53M | 53K | 5.17M | 53K | 50.32K | 1.51M | 3.8M | 10.26M | 5.4M | -3.65M | 4.15M | 4.28M |
| Total Assets | 40.56M | 44.18M | 45.75M | 47.99M | 50.78M | 47.37M | 47.8M | 53.43M | 47.07M | 53.26M | 47.58M | 52.44M |
| Asset Turnover | 0.21x | 0.21x | 0.20x | 0.19x | 0.18x | 0.19x | 0.17x | 0.18x | 0.18x | 0.15x | 0.16x | 0.17x |
| Asset Growth % | -20.12% | -6.73% | -4.3% | -10.18% | 7.88% | -11.06% | 0.48% | 1.87% | -18.09% | -15.77% | -23.6% | -26.35% |
| Total Current Liabilities | 16.3M | 9.71M | 10.11M | 9.84M | 9.74M | 9.82M | 8.43M | 10.34M | 13.42M | 14.55M | 11.97M | 10.35M |
| Accounts Payable | 3.13M | 2.87M | 3.04M | 3.39M | 3.33M | 3.34M | 2.34M | 3.05M | 2.4M | 3.8M | 3.44M | 2.84M |
| Days Payables Outstanding | 98.77 | 111.76 | 104.91 | 109.07 | 119.04 | -1.05K | 60.29 | 105.95 | 133.36 | 142 | 90.13 | 77.98 |
| Short-Term Debt | 7.21M | 541K | 518K | 0 | 0 | 0 | 0 | 0 | 2.5M | 2.5M | 950.54K | 114.38K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 561K | 546.03K | 419.33K | 0 | 0 | 0 | 1.38M | 1.63M | 1.58M |
| Other Current Liabilities | 5.96M | 6.3M | 6.56M | 2M | 796.92K | 865.51K | 837.59K | 1.3M | 1.6M | 3.15M | 5.95M | 5.82M |
| Current Ratio | 1.09x | 2.13x | 2.11x | 2.34x | 2.61x | 2.20x | 1.97x | 2.12x | 1.49x | 1.77x | 1.61x | 2.28x |
| Quick Ratio | 0.81x | 1.58x | 1.71x | 1.96x | 2.30x | 1.92x | 1.58x | 1.71x | 1.21x | 1.51x | 1.36x | 2.09x |
| Cash Conversion Cycle | 136.54 | 138.57 | 94.51 | 73.07 | 60.97 | 13.97 | 101.6 | 125.82 | 91.08 | 65.1 | 60.32 | 33.09 |
| Total Non-Current Liabilities | 22.07M | 28.57M | 26.62M | 26.56M | 26.5M | 26.44M | 26.37M | 26.35M | 14.72M | 15.44M | 17.09M | 18M |
| Long-Term Debt | 11.75M | 16.67M | 26.62M | 14.38M | 14.19M | 14M | 13.81M | 13.67M | 1.93M | 2.54M | 4.2M | 5.02M |
| Capital Lease Obligations | 0 | 11.9M | 0 | 12.19M | 12.32M | 12.44M | 12.57M | 12.68M | 12.79M | 12.9M | 12.89M | 12.98M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.71M | 0 | 0 |
| Other Non-Current Liabilities | 10.31M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 38.37M | 38.28M | 36.73M | 36.4M | 36.24M | 36.26M | 34.8M | 36.69M | 28.14M | 29.99M | 29.06M | 28.35M |
| Total Debt | 18.96M | 29.11M | 27.14M | 27.06M | 26.98M | 26.89M | 26.81M | 26.77M | 17.61M | 18.31M | 18.04M | 18.11M |
| Net Debt | 14.15M | 22.86M | 19.6M | 16.85M | 15.39M | 23.61M | 21.12M | 18.31M | 9M | 4.18M | 9.68M | 4.96M |
| Debt / Equity | 8.64x | 4.93x | 3.01x | 2.34x | 1.85x | 2.42x | 2.06x | 1.60x | 0.93x | 0.79x | 0.97x | 0.75x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -3.55x | -6.37x | -4.54x | 4.16x | -1.44x | -14.34x | -2.97x | -22.84x | -914.18x | -132.04x | -272.05x | -741.21x |
| Total Equity | 2.19M | 5.9M | 9.02M | 11.59M | 14.54M | 11.11M | 13M | 16.74M | 18.93M | 23.28M | 18.51M | 24.09M |
| Equity Growth % | -84.91% | -46.85% | -30.61% | -30.77% | -23.17% | -52.28% | -29.78% | -30.54% | -34.63% | -34.2% | -52.71% | -49.34% |
| Book Value per Share | 0.03 | 0.09 | 0.14 | 0.17 | 0.24 | 0.20 | 0.24 | 0.31 | 0.35 | 0.52 | 0.42 | 0.55 |
| Total Shareholders' Equity | 2.19M | 5.9M | 9.02M | 11.59M | 14.54M | 11.11M | 13M | 16.74M | 18.93M | 23.28M | 18.51M | 24.09M |
| Common Stock | 63K | 63K | 63K | 63K | 62.53K | 54.83K | 54.5M | 54.31K | 54.29K | 54.24K | 44.44K | 44.19K |
| Retained Earnings | -317.34M | -312.21M | -306.71M | -303.54M | -305.49M | -304.01M | -295.34M | -293.01M | -288.86M | -282.51M | -276.67M | -267.48M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -2.1M | -2.98M | -3.84M | -3.96M | 1.52M | 4.25M | -156.93K | 2.17M | 1.75M | 529.32K | 2.98M | 1.33M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |